Searchable abstracts of presentations at key conferences in endocrinology

ea0035p265 | Clinical case reports Thyroid/Others | ECE2014

Acute necrotizing pancreatitis as first manifestation of primary hyperparathyroidism

Tuzun Dilek , Kara Banu , Irkorucu Oktay

We present a case report of a young female patient with hypercalcemia-induced acute necrotizing pancreatitis as first manifestation of a benign parathyroid adenoma.Case: A 46-year-old female presented at the emergency room with a sudden attack of severe epigastric pain and vomiting. Clinical examination revealed a severely ill patient, a silent abdomen which was distended with painful percussion and palpation of the epigastrium. Blood analysis showed sig...

ea0090ep774 | Pituitary and Neuroendocrinology | ECE2023

The role of artificial intelligence algorithm in predicting the prognosis in prolactinomas

Kara Zehra , Sulu Cem , Demir Ahmet Numan , Kadioglu Pinar

Objective: To test the utility of the artificial learning algorithms using magnetic resonance (MR) images of the pituitary gland in predicting the prognosis of prolactinoma.Methods: This single-center, retrospective study was conducted in the Pituitary Center of a tertiary care university hospital. A total of 224 images derived from 38 patients with treatment-refractory prolactinoma, 23 patients with prolactinoma remission and 51 healthy individuals were...

ea0049ep620 | Diabetes therapy | ECE2017

Palpable purpura in an uncontrolled diabetic patient: an uncommon possible side effect of linagliptin

Topaloglu Omercan , Evren Bahri , Kara Mahmut , Yucel Seyfullah , Sahin Ibrahim

Introduction: Incretin based therapeutics have commonly been used in the last years for the management of patients with type 2 diabetes mellitus (DM). Linagliptin is a member of “dipeptidyl peptidase 4” (DPP-4) inhibitors and often preferred owing to some advantages over the others. We present a diabetic case developing skin findings after the initiation of linagliptin.Case: 66 year-old woman with a history of type 2 DM for 10 years was admitte...

ea0032p219 | Clinical case reports – Pituitary/Adrenal | ECE2013

Wegener granulomatosis as an uncommon cause of panhypopituitarism in childhood

Demirel Fatma , Kara Ozlem , Acar Banu Celikel , Cakar Nilgun

Wegener granulomatosis is an antineutrophil cytoplasmic antibody (cANCA)-associated, multi-system, necrotizing granulomatous vasculitis. Inflammation of nasal or oral mucosa, lung and kidney involvements are typical in the course of the disease. It was first described by Friedrich Wegener in 1939, and has an incidence rate of 1 in 100 000 people, often observed in individuals aged between 25 and 50 years, but uncommon in children and adolescent. In rare cases, pituitary involv...

ea0020p388 | Diabetes and Cardiovascular | ECE2009

Relationship between adipocytokines and cardiovascular risk factors in patients with type 2 diabetes mellitus

Uslu Sema , Kebapci Nur , Kara Mehmet , Bal Cengiz

Aims: In this study, we examined the relationships between levels of adipocytokines and traditional and non-traditional cardiovascular risk markers in patients with type 2 diabetes mellitus (T2DM).Methods: Serum leptin, resistin, adiponectin, visfatin, high sensitive C-reactive protein (hsCRP), homocystein, asymetric dimethylarginine (ADMA), fasting glucose, insulin, glycated haemoglobin (HbA1C) and full lipid and lipoprotein profile, systolic...

ea0020p562 | Neuroendocrinology, Pituitary and Behaviour | ECE2009

Heart rate variability of young men with hypogonadotropic hypogonadism

Deniz Ferhat , Ermis Necip , Kepez Alper , Kara Batuhan , Omer Azal

Objective: There is little data available regarding the effects of male sex hormones on cardiac autonomic function. The aim of this study is to evaluate the association between male sex steroids and cardiac autonomic function by comparing heart rate variability (HRV) parameters of young male hypogonadotropic hypogonadism patients to those of healthy controls.Design: The study consisted of 22 male hypogonadotropic hypogonadism patients (mean age 20.8&#177...

ea0011p287 | Diabetes, metabolism and cardiovascular | ECE2006

Plasma concentrations of asymmetric dimethyl arginine and total homocysteine in siblings of type 2 diabetes mellitus

Guldiken S , Karadag CH , Arikan E , Demir M , Kara M

Diabetes mellitus (DM) includes a group of carbohydrate metabolism disorders that is characterized by hyperglycemia and leads long-term macro- and microvascular complications. Also siblings of type 2 diabetic patients have increased relative risk of micro and macrovasculer outcome of DM even though their plasma glucose levels in normal range. Genetically determined hyperinsulinemia, insulin resistance and associated dyslipidemia have crucial role in the processes of vascular a...

ea0006dp1 | Diabetes, metabolism and cardiovascular | SFE2003

Silent myocardial ischemia in patients with type II diabetes mellitus without the clinical manifestations of ischemic heart disease in Turkish population

Ugur-Altun B , Altun A , Guldiken S , Kara M , Tugrul A

Accelerated coronary and peripheral vascular atherosclerosis is one of the most common and chronic complications of diabetes mellitus. A relatively recently analysed aspect of coronary artery disease in this condition is its silent nature. We studied silent myocardial ischaemia (SMI) in unselected consecutive middle aged asymptomatic patients with type II diabetes by treadmill exercise test.Ninety four asymptomatic type II diabetics between the ages 36 a...

ea0056p985 | Clinical case reports - Thyroid/Others | ECE2018

A silent thyroiditis in the remission period of Graves’ disease

Kirac Cem Onur , Ipekci Suleyman , Gedik Gonca Kara , Kebapcilar Levent

Silent thyroiditis is characterized by the destructive thyroid inflammation and is considered to be a chronic autoimmune thyroid disease, although the etiology could not have been fully explained. On the other hand, Graves’ disease is autoimmune phenomena as well as silent thyroiditis and silent thyroiditis has been classified as part of the spectrum of Graves’ disease. Although, the thyroid stimulating antibody (TSAb) are found positive in most of Graves’ disea...

ea0090p268 | Late-Breaking | ECE2023

Salivary Alpha-Amylase Activity in Patients with Acromegaly: A Preliminary Report

Erol Selvinaz , Cil Sen Esra , Yener Ozturk Feyza , Kara ZMY , Sarac Zeynep , Altuntas Yuksel

Objective: It has been argued that salivary alpha-amylase (sAA) is a potential indirect sympathoadrenal medullary (SAM) system activity marker. This study aimed to look at sAA to assess the sympathetic nervous system in acromegaly patients.Subjects and Methods: A total of 31 individuals with acromegaly and 30 controls were enrolled in this prospective, single-center investigation. Saliva samples were taken from individuals with acromegaly and controls in...